BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
One perk to marrying Richard Marx later in life? 'We don't have time' for stupid arguments, says Daisy Fuentes. - 2Experiences in Natural life Protection: Individual Progressives' Excursions
- 3Kids with smartphones by age 12 are at higher risk of health issues, study finds
- 4Figure out How to Plan for Your Web-based Degree monetarily
- 5Ober Gabelhorn glacier reveals remains of man missing for over three decades
- Watch Blue Origin's huge New Glenn rocket ace its epic landing on a ship at sea (video)
- At least 171 measles cases confirmed in 9 states, CDC data shows
- Watch SpaceX launch NASA's Pandora exoplanet-studying satellite on Jan. 11
- Gulf of Mexico oil spill spread hundreds of miles, killed wildlife and polluted Mexican reserves
- Earth’s magnetic field protects life on Earth from radiation, but it can move, and the magnetic poles can even flip
- The most effective method to Redesign the Sound Framework in Your Smash 1500.
- Mom finds out she has cancer after noticing something was off while breastfeeding
- 2024 Style: The It-Things You Want in Your Closet
- Alice Wong, founder of the Disability Visibility Project, dies at 51
